SIC
PFE icon

Shoker Investment Counsel’s Pfizer PFE Stock Holding History

Shoker Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68M Sell
95,378
-5,518
-5% -$147K 0.8% 36
2025
Q4 		$2.51M Sell
100,896
-12,582
-11% -$317K 0.74% 42
2025
Q3 		$2.89M Sell
113,478
-111
-0.1% -$2.74K 0.85% 36
2025
Q2 		$2.75M Sell
113,589
-8,818
-7% -$206K 0.86% 38
2025
Q1 		$3.1M Sell
122,407
-3,035
-2% -$79.4K 1.05% 30
2024
Q4 		$3.33M Buy
125,442
+1,323
+1% +$35.9K 1.12% 25
2024
Q3 		$3.59M Sell
124,119
-14,017
-10% -$409K 1.21% 23
2024
Q2 		$3.87M Buy
138,136
+91,554
+197% +$2.52M 1.36% 18
2024
Q1 		$1.29M Sell
46,582
-6,523
-12% -$181K 0.46% 51
2023
Q4 		$1.53M Buy
53,105
+1,442
+3% +$43.6K 0.59% 47
2023
Q3 		$1.71M Sell
51,663
-10
-0% -$354 0.74% 41
2023
Q2 		$1.9M Sell
51,673
-79
-0.2% -$3.08K 0.79% 40
2023
Q1 		$2.11M Sell
51,752
-175
-0.3% -$7.56K 0.92% 36
2022
Q4 		$2.66M Sell
51,927
-216
-0.4% -$10.4K 1.19% 26
2022
Q3 		$2.28M Buy
52,143
+2,189
+4% +$106K 1.2% 30
2022
Q2 		$2.62M Buy
49,954
+2,277
+5% +$116K 1.39% 25
2022
Q1 		$2.47M Sell
47,677
-82
-0.2% -$4.25K 1.22% 26
2021
Q4 		$2.82M Sell
47,759
-765
-2% -$37.9K 1.29% 24
2021
Q3 		$2.09M Sell
48,524
-15
-0% -$665 1.04% 30
2021
Q2 		$1.9M Buy
48,539
+952
+2% +$37K 0.95% 34
2021
Q1 		$1.72M Sell
47,587
-730
-2% -$25.9K 0.91% 38
2020
Q4 		$1.78M Buy
48,317
+195
+0.4% +$7.15K 1% 31
2020
Q3 		$1.68M Buy
48,122
+543
+1% +$19K 1.1% 29
2020
Q2 		$1.48M Buy
47,579
+557
+1% +$18.9K 1.03% 33
2020
Q1 		$1.46M Buy
47,022
+2,691
+6% +$91.7K 1.23% 29
2019
Q4 		$1.65M Buy
44,331
+470
+1% +$16.7K 1.1% 30
2019
Q3 		$1.5M Sell
43,861
-1,303
-3% -$47.4K 1.07% 32
2019
Q2 		$1.86M Buy
45,164
+470
+1% +$18.7K 1.35% 22
2019
Q1 		$1.8M Buy
44,694
+694
+2% +$27.8K 1.33% 24
2018
Q4 		$1.82M Buy
44,000
+993
+2% +$41.2K 1.53% 18
2018
Q3 		$1.8M Sell
43,007
-5
-0% -$192 1.3% 20
2018
Q2 		$1.48M Buy
43,012
+914
+2% +$31.2K 1.1% 25
2018
Q1 		$1.42M Buy
42,098
+1,478
+4% +$50.8K 1.08% 28
2017
Q4 		$1.4M Buy
40,620
+64
+0.2% +$2.18K 1.01% 30
2017
Q3 		$1.37M Buy
40,556
+524
+1% +$16.8K 1.04% 29
2017
Q2 		$1.27M Buy
40,032
+1,450
+4% +$45.7K 1% 34
2017
Q1 		$1.25M Sell
38,582
-410
-1% -$12.9K 1.05% 32
2016
Q4 		$1.2M Buy
38,992
+1,205
+3% +$36.8K 0.99% 33
2016
Q3 		$1.21M Buy
37,787
+704
+2% +$23.5K 1.03% 30
2016
Q2 		$1.24M Buy
37,083
+41
+0.1% +$1.31K 1.1% 28
2016
Q1 		$1.04M Buy
37,042
+6,580
+22% +$188K 0.98% 34
2015
Q4 		$932K Buy
30,462
+2,165
+8% +$68.1K 0.93% 34
2015
Q3 		$843K Sell
28,297
-621
-2% -$19.9K 0.89% 37
2015
Q2 		$919K Sell
28,918
-479
-2% -$15.6K 0.86% 39
2015
Q1 		$970K Sell
29,397
-1,399
-5% -$44.5K 0.92% 38
2014
Q4 		$910K Buy
30,796
+2,783
+10% +$79.8K 0.84% 41
2014
Q3 		$785K Sell
28,013
-2,864
-9% -$80.4K 0.73% 45
2014
Q2 		$869K Sell
30,877
-17
-0.1% -$485 0.77% 45
2014
Q1 		$941K Buy
30,894
+125
+0.4% +$3.73K 0.88% 40
2013
Q4 		$894K Buy
+30,769
New +$895K 0.82% 43

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Shoker Investment Counsel's PFE Position: Q1 2026 in Review

Shoker Investment Counsel reduced its Pfizer (PFE) stake by 5.5% in Q1 2026, selling an estimated $147K and leaving 95,378 shares worth $2.68M. The position accounts for 0.8% of the portfolio, ranked #36.

Shoker Investment Counsel first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.87M in Q2 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Shoker Investment Counsel held 95,378 shares of Pfizer worth $2.68M as of Q1 2026.
  • Shoker Investment Counsel sold 5,518 Pfizer shares in Q1 2026, an estimated $147K.
  • Pfizer made up 0.8% of Shoker Investment Counsel's portfolio in Q1 2026, its #36 holding.
  • Shoker Investment Counsel first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • Shoker Investment Counsel's Pfizer position peaked at $3.87M in Q2 2024.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Shoker Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.